KKRC
QHC

Kohlberg Kravis Roberts & Co’s Quorum Health Corporation QHC Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio QHC Stock Details QHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,988,781
Closed -$345K – 74
2020
Q2 		$345K Hold
2,988,781
– – ﹤0.01% 63
2020
Q1 		$1.35M Hold
2,988,781
– – 0.01% 42
2019
Q4 		$2.86M Hold
2,988,781
– – 0.01% 45
2019
Q3 		$3.62M Hold
2,988,781
– – 0.02% 41
2019
Q2 		$4.15M Hold
2,988,781
– – 0.05% 47
2019
Q1 		$4.18M Hold
2,988,781
– – 0.06% 42
2018
Q4 		$8.64M Hold
2,988,781
– – 0.16% 38
2018
Q3 		$17.5M Hold
2,988,781
– – 0.2% 31
2018
Q2 		$14.9M Hold
2,988,781
– – 0.17% 27
2018
Q1 		$24.4M Hold
2,988,781
– – 0.3% 19
2017
Q4 		$18.6M Buy
2,988,781
+135,000
+5% +$678K 0.18% 32
2017
Q3 		$14.8M Hold
2,853,781
– – 0.17% 30
2017
Q2 		$11.8M Buy
2,853,781
+1,190,600
+72% +$4.89M 0.13% 34
2017
Q1 		$9.05M Buy
1,663,181
+1,387,064
+502% +$11.3M 0.16% 32
2016
Q4 		$2.01M Buy
+276,117
New +$1.66M 0.03% 46

Kohlberg Kravis Roberts & Co's QHC Position: Q3 2020 in Review

Kohlberg Kravis Roberts & Co sold out of Quorum Health Corporation (QHC) in Q3 2020, closing a stake of 2,988,781 shares — an estimated $345K sold.

Kohlberg Kravis Roberts & Co first reported a position in QHC in Q4 2016 and held it in 15 quarters. The position peaked at $24.4M in Q1 2018. 0 funds tracked by Wall St. Rank hold QHC as of Q3 2020.

  • Kohlberg Kravis Roberts & Co reported no remaining Quorum Health Corporation position as of Q3 2020 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 2,988,781 Quorum Health Corporation shares in Q3 2020, an estimated $345K.
  • Kohlberg Kravis Roberts & Co first reported a position in Quorum Health Corporation in Q4 2016 and held it in 15 quarters.
  • Kohlberg Kravis Roberts & Co's Quorum Health Corporation position peaked at $24.4M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Quorum Health Corporation as of Q3 2020.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2020, filed 16 Nov 2020.